NL189199C - Werkwijze ter bereiding van farmaceutische preparaten met werking op het centraal zenuwstelsel op basis van benz(aryl)azepinederivaten, de verkregen gevormde farmaceutische preparaten, alsmede werkwijze ter bereiding van de toe te passen benz(aryl)azepinederivaten. - Google Patents

Werkwijze ter bereiding van farmaceutische preparaten met werking op het centraal zenuwstelsel op basis van benz(aryl)azepinederivaten, de verkregen gevormde farmaceutische preparaten, alsmede werkwijze ter bereiding van de toe te passen benz(aryl)azepinederivaten.

Info

Publication number
NL189199C
NL189199C NLAANVRAGE7504075,A NL7504075A NL189199C NL 189199 C NL189199 C NL 189199C NL 7504075 A NL7504075 A NL 7504075A NL 189199 C NL189199 C NL 189199C
Authority
NL
Netherlands
Prior art keywords
pharmaceutical preparations
benz
aryl
preparing
preparation
Prior art date
Application number
NLAANVRAGE7504075,A
Other languages
English (en)
Dutch (nl)
Other versions
NL7504075A (nl
NL189199B (nl
Original Assignee
Akzo Nv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=19823518&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=NL189199(C) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Akzo Nv filed Critical Akzo Nv
Priority to NLAANVRAGE7504075,A priority Critical patent/NL189199C/xx
Priority to US05/669,544 priority patent/US4062848A/en
Priority to IE614/76A priority patent/IE42969B1/en
Priority to ZA761756A priority patent/ZA761756B/xx
Priority to AU12361/76A priority patent/AU493450B2/en
Priority to GB12270/76A priority patent/GB1543171A/en
Priority to CH388676A priority patent/CH622261A5/de
Priority to DK142676AA priority patent/DK142498B/da
Priority to FI760884A priority patent/FI62087C/fi
Priority to LU74680A priority patent/LU74680A1/xx
Priority to FR7609686A priority patent/FR2305986A1/fr
Priority to SE7603931A priority patent/SE422941B/xx
Priority to JP51037678A priority patent/JPS5942678B2/ja
Priority to DE19762614406 priority patent/DE2614406A1/de
Priority to BE165832A priority patent/BE840362A/xx
Priority to ES446634A priority patent/ES446634A1/es
Priority to CA249,439A priority patent/CA1076571A/en
Priority to HU76AO437A priority patent/HU179401B/hu
Publication of NL7504075A publication Critical patent/NL7504075A/xx
Priority to ES459348A priority patent/ES459348A1/es
Publication of NL189199B publication Critical patent/NL189199B/xx
Publication of NL189199C publication Critical patent/NL189199C/xx
Application granted granted Critical
Priority to NL940007C priority patent/NL940007I2/nl

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/72—Nitrogen atoms
    • C07D213/73—Unsubstituted amino or imino radicals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/72—Nitrogen atoms
    • C07D213/75—Amino or imino radicals, acylated by carboxylic or carbonic acids, or by sulfur or nitrogen analogues thereof, e.g. carbamates
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04—Ortho-condensed systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/12—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains three hetero rings
    • C07D471/14—Ortho-condensed systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
NLAANVRAGE7504075,A 1975-04-05 1975-04-05 Werkwijze ter bereiding van farmaceutische preparaten met werking op het centraal zenuwstelsel op basis van benz(aryl)azepinederivaten, de verkregen gevormde farmaceutische preparaten, alsmede werkwijze ter bereiding van de toe te passen benz(aryl)azepinederivaten. NL189199C (nl)

Priority Applications (20)

Application Number Priority Date Filing Date Title
NLAANVRAGE7504075,A NL189199C (nl) 1975-04-05 1975-04-05 Werkwijze ter bereiding van farmaceutische preparaten met werking op het centraal zenuwstelsel op basis van benz(aryl)azepinederivaten, de verkregen gevormde farmaceutische preparaten, alsmede werkwijze ter bereiding van de toe te passen benz(aryl)azepinederivaten.
US05/669,544 US4062848A (en) 1975-04-05 1976-03-23 Tetracyclic compounds
IE614/76A IE42969B1 (en) 1975-04-05 1976-03-23 Tetracyclic compounds
ZA761756A ZA761756B (en) 1975-04-05 1976-03-23 Tetracyclic compounds
AU12361/76A AU493450B2 (en) 1976-03-25 Diazolo, diazino and diazepino [1,2-a] otrudi azeoube derivatives
GB12270/76A GB1543171A (en) 1975-04-05 1976-03-26 Tetracyclic compounds
CH388676A CH622261A5 (fi) 1975-04-05 1976-03-29
DK142676AA DK142498B (da) 1975-04-05 1976-03-30 Analogifremgangsmåde til fremstilling af benzopyridoazepinderivater.
FI760884A FI62087C (fi) 1975-04-05 1976-04-01 Foerfarande foer framstaellning av 1,2,3,4,10,14b-hexahydrobenso(c)pyrazino(1,2-a)pyridoazepinderivat med antihistamin- oc centralnervstimulerande aktivitet
CA249,439A CA1076571A (en) 1975-04-05 1976-04-02 Tetracyclic derivatives of benzo-pyrido azepines
LU74680A LU74680A1 (fi) 1975-04-05 1976-04-02
SE7603931A SE422941B (sv) 1975-04-05 1976-04-02 Analogiforfarande for framstellning av tetracykliska pyrido-bensazepinforeningar
JP51037678A JPS5942678B2 (ja) 1975-04-05 1976-04-02 四環式化合物及びその製法
DE19762614406 DE2614406A1 (de) 1975-04-05 1976-04-02 Tetracyclische verbindungen, verfahren zu deren herstellung und arzneimittel, enthaltend diese verbindungen
BE165832A BE840362A (fr) 1975-04-05 1976-04-02 Composes tetracycliques contenant un noyau azepine
ES446634A ES446634A1 (es) 1975-04-05 1976-04-02 Procedimiento para preparar compuestos tetraacidicos.
FR7609686A FR2305986A1 (fr) 1975-04-05 1976-04-02 Composes tetracycliques contenant un noyau azepine
HU76AO437A HU179401B (en) 1975-04-05 1976-04-05 Process for preparing tetracuclic benzo-pyrazino/imidazo,diazepino/-pyrido-azepine derivatives further pharmaceutical compositions containing thereof
ES459348A ES459348A1 (es) 1975-04-05 1977-05-31 Procedimiento para preparar compuestos tetraciclicos.
NL940007C NL940007I2 (nl) 1975-04-05 1994-04-21 Werkwijze ter bereiding van farmaceutische preparaten met werking op het centraal zenuwstelsel op basis van benz(aryl)azepinederivaten, de verkregen gevormde farmaceutische preparaten, alsmede werkwi jze ter bereiding van de toe te passen benz(aryl)azepinederivaten.

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
NLAANVRAGE7504075,A NL189199C (nl) 1975-04-05 1975-04-05 Werkwijze ter bereiding van farmaceutische preparaten met werking op het centraal zenuwstelsel op basis van benz(aryl)azepinederivaten, de verkregen gevormde farmaceutische preparaten, alsmede werkwijze ter bereiding van de toe te passen benz(aryl)azepinederivaten.

Publications (3)

Publication Number Publication Date
NL7504075A NL7504075A (nl) 1976-10-07
NL189199B NL189199B (nl) 1992-09-01
NL189199C true NL189199C (nl) 1993-02-01

Family

ID=19823518

Family Applications (2)

Application Number Title Priority Date Filing Date
NLAANVRAGE7504075,A NL189199C (nl) 1975-04-05 1975-04-05 Werkwijze ter bereiding van farmaceutische preparaten met werking op het centraal zenuwstelsel op basis van benz(aryl)azepinederivaten, de verkregen gevormde farmaceutische preparaten, alsmede werkwijze ter bereiding van de toe te passen benz(aryl)azepinederivaten.
NL940007C NL940007I2 (nl) 1975-04-05 1994-04-21 Werkwijze ter bereiding van farmaceutische preparaten met werking op het centraal zenuwstelsel op basis van benz(aryl)azepinederivaten, de verkregen gevormde farmaceutische preparaten, alsmede werkwi jze ter bereiding van de toe te passen benz(aryl)azepinederivaten.

Family Applications After (1)

Application Number Title Priority Date Filing Date
NL940007C NL940007I2 (nl) 1975-04-05 1994-04-21 Werkwijze ter bereiding van farmaceutische preparaten met werking op het centraal zenuwstelsel op basis van benz(aryl)azepinederivaten, de verkregen gevormde farmaceutische preparaten, alsmede werkwi jze ter bereiding van de toe te passen benz(aryl)azepinederivaten.

Country Status (17)

Country Link
US (1) US4062848A (fi)
JP (1) JPS5942678B2 (fi)
BE (1) BE840362A (fi)
CA (1) CA1076571A (fi)
CH (1) CH622261A5 (fi)
DE (1) DE2614406A1 (fi)
DK (1) DK142498B (fi)
ES (2) ES446634A1 (fi)
FI (1) FI62087C (fi)
FR (1) FR2305986A1 (fi)
GB (1) GB1543171A (fi)
HU (1) HU179401B (fi)
IE (1) IE42969B1 (fi)
LU (1) LU74680A1 (fi)
NL (2) NL189199C (fi)
SE (1) SE422941B (fi)
ZA (1) ZA761756B (fi)

Families Citing this family (74)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4515792A (en) * 1982-09-30 1985-05-07 Ciba-Geigy Corporation Tetracyclic heterocycles and antidepressant compositions thereof
JPS6336682A (ja) * 1986-07-31 1988-02-17 Matsushita Electric Ind Co Ltd カセツト方式文字放送受信機
JPS63177670A (ja) * 1987-01-31 1988-07-21 Fujitsu General Ltd 文字放送受信装置
JPS63215179A (ja) * 1987-03-03 1988-09-07 Fujitsu General Ltd 受信装置
JPH055746Y2 (fi) * 1988-04-27 1993-02-15
CA2026925A1 (en) * 1989-10-05 1991-04-06 Hiroshi Fukumi Tetracyclic compounds having anti-allergic and anti-asthmatic activities, their preparation and use
EP0539164A1 (en) * 1991-10-23 1993-04-28 Sankyo Company Limited Nitrogen-containing tetracyclic compounds having anti-allergic and anti-asthmatic activities, their preparation and use
IL121076A (en) * 1996-06-19 2000-10-31 Akzo Nobel Nv Pharmaceutical combinations comprising mirtazapine and one or more selective serotonin reuptake inhibitors
WO1999051237A1 (en) * 1998-04-02 1999-10-14 Akzo Nobel N.V. Oral liquid antidepressant solution
US6545149B2 (en) 1999-04-19 2003-04-08 Teva Pharmaceutical Industries Ltd. Synthesis and crystallization of piperazine ring-containing compounds
KR20020015313A (ko) 1999-04-19 2002-02-27 추후보정 피페라진 고리의 신규한 합성방법
IL146023A0 (en) * 1999-04-19 2002-07-25 Teva Pharma Novel synthesis and crystallization of piperazine ring-containing compounds
AU781221B2 (en) * 1999-04-19 2005-05-12 Teva Pharmaceutical Industries Ltd. Novel synthesis and crystallization of piperazine ring-containing compounds
US6281207B1 (en) * 1999-09-15 2001-08-28 Reed Richter Treatment of movement disorders by administration of mirtazapine
AU6476300A (en) * 1999-09-30 2001-05-10 Sumika Fine Chemicals Co., Ltd. Process for the preparation of a piperazine derivative
AU6019900A (en) 1999-11-24 2001-06-04 Sumika Fine Chemicals Co., Ltd. Anhydrous mirtazapine crystals and process for producing the same
AU6474200A (en) 1999-12-13 2001-06-18 Sumika Fine Chemicals Co., Ltd. Process for the preparation of a pyridinemethanol compound
RU2268725C2 (ru) * 2000-01-19 2006-01-27 Акцо Нобель Н.В. Комбинация лекарственных препаратов, включающая миртазапин, для лечения депрессии и связанных расстройств
CN101229170A (zh) 2000-02-11 2008-07-30 欧加农股份有限公司 米氮平用于治疗睡眠障碍的用途
IN190478B (fi) * 2000-11-07 2003-08-02 Sun Pharmaceutical Ind Ltd
US6660730B2 (en) 2000-11-27 2003-12-09 Sumika Fine Chemicals Co., Ltd. Anhydrous mirtazapine and process for preparing the same
US6399310B1 (en) 2001-02-12 2002-06-04 Akzo Nobel N.V. Methods for improving the therapeutic response of humans having major depression and carrying the gene for apolipoprotein E4
US20030105082A1 (en) * 2001-12-03 2003-06-05 Murphy Greer Marechal Methods for improving the therapeutic response of humans having major depression and carrying the gene for apolipoprotein E4
JP2004532190A (ja) * 2001-02-12 2004-10-21 アクゾ・ノベル・エヌ・ベー アポリポタンパク質ｅ４の遺伝子の遺伝子型決定により大うつ病の治療を改善するための方法
KR20030078086A (ko) 2001-03-01 2003-10-04 테바 파마슈티컬 인더스트리즈 리미티드 미르타자핀 중간체의 제조방법
US7355042B2 (en) * 2001-10-16 2008-04-08 Hypnion, Inc. Treatment of CNS disorders using CNS target modulators
CZ296992B6 (cs) * 2002-10-03 2006-08-16 Zentiva, A.S. Príprava a izolace 2-substituovaných-3-pyridylkarboxylových kyselin, jejich karboxylových solí a produktu redukce
US20040192754A1 (en) * 2003-03-24 2004-09-30 Shapira Nathan Andrew Methods for treating idiopathic hyperhidrosis and associated conditions
UA83666C2 (ru) * 2003-07-10 2008-08-11 Н.В. Органон Способ получения энантиомерно чистого миртазапина
US7838029B1 (en) * 2003-07-31 2010-11-23 Watson Laboratories, Inc. Mirtazapine solid dosage forms
TW200538100A (en) * 2004-04-21 2005-12-01 Akzo Nobel Nv Mirtazapine salts
MXPA06013163A (es) * 2004-05-11 2007-02-13 Pfizer Prod Inc Combinacion de antipsicoticos atipicos y antagonistas del receptor 5-ht1b.
CA2575979A1 (en) * 2004-08-13 2006-02-23 Omeros Corporation Novel serotonin receptor ligands and their uses thereof
US20060039866A1 (en) * 2004-08-20 2006-02-23 Cypress Bioscience, Inc. Method for treating sleep-related breathing disorders
CA2576299A1 (en) * 2004-08-24 2006-03-02 Sumitomo Chemical Company, Limited Method for producing 2-(4-methyl-2-phenylpiperazine-1-yl)-3-cyanopiridine
JP4848704B2 (ja) * 2004-08-24 2011-12-28 住友化学株式会社 ２−（４−メチル−２−フェニルピペラジン−１−イル）−３−シアノピリジンの製造方法
TW200631584A (en) * 2004-11-15 2006-09-16 Akzo Nobel Nv A medicament related to mirtazapine for the treatment of hot flush
WO2006055854A2 (en) * 2004-11-17 2006-05-26 Cypress Bioscience, Inc. Methods for reducing the side effects associated with mirtazapine treatment
US20090306046A1 (en) * 2005-06-27 2009-12-10 N.V. Organon Method of treatment of hormone depletion induced vasomotor symptoms
CA2614289A1 (en) * 2005-07-08 2007-01-18 Braincells, Inc. Methods for identifying agents and conditions that modulate neurogenesis
CN1939918B (zh) * 2005-09-30 2010-09-01 北京德众万全医药科技有限公司 一种米氮平的制备方法
AU2006304787A1 (en) 2005-10-21 2007-04-26 Braincells, Inc. Modulation of neurogenesis by PDE inhibition
CA2625210A1 (en) 2005-10-31 2007-05-10 Braincells, Inc. Gaba receptor mediated modulation of neurogenesis
EP2218442A1 (en) 2005-11-09 2010-08-18 CombinatoRx, Inc. Methods, compositions, and kits for the treatment of ophthalmic disorders
US20090306383A1 (en) * 2005-11-14 2009-12-10 Sumitomo Chemical Company, Limited Method for Producing 2-(4-Methyl-2-Phenylpiperazin-1-Yl)Pyridine-3-Methanol
EP1792618A1 (en) 2005-11-30 2007-06-06 Rainer Freynhagen R-mirtazapine for the treatment of pain
WO2007101832A1 (en) * 2006-03-06 2007-09-13 N.V. Organon An improved method of weaning from hormonal treatment of hormone depletion induced vasomotor symptoms
US20100216734A1 (en) 2006-03-08 2010-08-26 Braincells, Inc. Modulation of neurogenesis by nootropic agents
AU2007249399A1 (en) 2006-05-09 2007-11-22 Braincells, Inc. Neurogenesis by modulating angiotensin
US7678808B2 (en) 2006-05-09 2010-03-16 Braincells, Inc. 5 HT receptor mediated neurogenesis
US7858611B2 (en) * 2006-05-09 2010-12-28 Braincells Inc. Neurogenesis by modulating angiotensin
US20070270413A1 (en) * 2006-05-22 2007-11-22 N.V. Organon Mirtazapine for the treatment of neuropathic pain
TW200815370A (en) * 2006-06-16 2008-04-01 Organon Nv Stereoselective synthesis of (S)-1-methyl-3-phenylpiperazine
EP2068872A1 (en) * 2006-09-08 2009-06-17 Braincells, Inc. Combinations containing a 4-acylaminopyridine derivative
US20100184806A1 (en) 2006-09-19 2010-07-22 Braincells, Inc. Modulation of neurogenesis by ppar agents
US20080167363A1 (en) * 2006-12-28 2008-07-10 Braincells, Inc Modulation of Neurogenesis By Melatoninergic Agents
EP2125017A2 (en) * 2007-01-11 2009-12-02 Braincells, Inc. Modulation of neurogenesis with use of modafinil
JP5192707B2 (ja) * 2007-03-22 2013-05-08 住友化学株式会社 ミルタザピンの製造方法
US7994314B2 (en) * 2007-04-11 2011-08-09 N.V. Organon Method for the preparation of an enantiomerically pure benzazepine
AR066005A1 (es) * 2007-04-11 2009-07-15 Organon Nv Un metodo para la preparacion de un enantiomero de una benzazepina tetraciclica
US20080255348A1 (en) * 2007-04-11 2008-10-16 N.V. Organon Method for the preparation of an enantiomer of a tetracyclic benzazepine
AR066004A1 (es) * 2007-04-11 2009-07-15 Organon Nv Un metodo para la preparacion de una benzazepina enantiomericamente pura
EP2167096A4 (en) * 2007-06-13 2010-07-14 Cypress Bioscience Inc IMPROVING TOLERANCE TO MIRTAZAPINE AND A SECOND ACTIVE INGREDIENT BY THE COMBINED USE OF THEM
JP2009018992A (ja) * 2007-07-10 2009-01-29 Sumitomo Chemical Co Ltd 光学活性ミルタザピンの製造方法
US8461389B2 (en) 2008-04-18 2013-06-11 University College Dublin, National University Of Ireland, Dublin Psycho-pharmaceuticals
WO2009128058A1 (en) 2008-04-18 2009-10-22 UNIVERSITY COLLEGE DUBLIN, NATIONAL UNIVERSITY OF IRELAND, DUBLIN et al Psycho-pharmaceuticals
CA2727573A1 (en) * 2008-06-25 2009-12-30 Pfizer Inc. Diaryl compounds and uses thereof
WO2010046851A1 (en) 2008-10-22 2010-04-29 Watson Pharma Private Limited Process for the preparation of 1- ( 3-hydroxymethylpyrid-2 -yl ) -2 -phenyl-4-methylpiperazine and mirtazapine
WO2010099217A1 (en) 2009-02-25 2010-09-02 Braincells, Inc. Modulation of neurogenesis using d-cycloserine combinations
CN102432594B (zh) * 2011-11-28 2013-09-11 山东鲁药制药有限公司 一种药物中间体1-（3-羟甲基吡啶-2-基）-2-苯基-4-甲基哌嗪的制备方法
CN103509020A (zh) * 2013-10-21 2014-01-15 山东鲁药制药有限公司 一种米氮平的合成方法
CN104356133A (zh) * 2014-11-25 2015-02-18 南京工业大学 一种制备抗抑郁药物米氮平的方法
JP6433809B2 (ja) * 2015-02-20 2018-12-05 株式会社トクヤマ １−（３−ヒドロキシメチルピリジル−２−）−２−フェニル−４−メチルピペラジンの製造方法
KR102540021B1 (ko) 2020-12-02 2023-06-07 (주)유케이케미팜 대량 생산에 적합한 미르타자핀의 제조방법

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL129434C (fi) * 1966-03-12
NL7202963A (fi) * 1972-03-07 1973-09-11
US3959470A (en) * 1972-11-28 1976-05-25 Mikhail Davidovich Mashkovsky Psychotropic medicinal preparation

Also Published As

Publication number Publication date
FI62087C (fi) 1982-11-10
FR2305986B1 (fi) 1980-06-13
ES459348A1 (es) 1978-03-16
FI760884A (fi) 1976-10-06
JPS5942678B2 (ja) 1984-10-16
IE42969B1 (en) 1980-11-19
CH622261A5 (fi) 1981-03-31
DK142498C (fi) 1981-07-06
AU1236176A (en) 1977-09-29
LU74680A1 (fi) 1976-11-11
NL940007I2 (nl) 1994-10-17
NL7504075A (nl) 1976-10-07
NL189199B (nl) 1992-09-01
IE42969L (en) 1976-10-05
SE7603931L (sv) 1976-10-06
CA1076571A (en) 1980-04-29
GB1543171A (en) 1979-03-28
HU179401B (en) 1982-10-28
DK142676A (fi) 1976-10-06
ES446634A1 (es) 1977-11-01
DK142498B (da) 1980-11-10
NL940007I1 (nl) 1994-06-01
DE2614406C2 (fi) 1992-02-20
JPS51122099A (en) 1976-10-25
FR2305986A1 (fr) 1976-10-29
ZA761756B (en) 1977-03-30
BE840362A (fr) 1976-10-04
US4062848A (en) 1977-12-13
DE2614406A1 (de) 1976-10-14
FI62087B (fi) 1982-07-30
SE422941B (sv) 1982-04-05

Similar Documents

Publication Publication Date Title
NL189199C (nl) Werkwijze ter bereiding van farmaceutische preparaten met werking op het centraal zenuwstelsel op basis van benz(aryl)azepinederivaten, de verkregen gevormde farmaceutische preparaten, alsmede werkwijze ter bereiding van de toe te passen benz(aryl)azepinederivaten.
NL180211C (nl) Werkwijze voor de bereiding van kosmetische preparaten en werkwijze voor de bereiding van daarin te gebruiken benzylideenkamfer-derivaten.
NL181628C (nl) Werkwijze voor het bereiden van farmaceutische preparaten met prostaglandine-achtige werking, alsmede werkwijze voor het bereiden van 9alfa,11alfa,15alfa-trihydroxy-prosta-4,5,13-trieenzuurderivaten, geschikt voor gebruik bij de eerstgenoemde werkwijze.
NL7410343A (nl) Werkwijze voor de bereiding van prostaanzuur derivaten.
NL167151C (nl) Werkwijze ter bereiding van geneesmiddelen met anti-parasitaire werking op basis van halogeen bevatten- de 2,2'-methyleendifenolderivaten, alsmede werkwijze ter bereiding van deze geneeskrachtige verbindingen.
NL7412030A (nl) Werkwijze voor het bereiden van esters van ami- nozuren, werkwijze ter bereiding van farmaceu- tische preparaten, alsmede de door toepassing daarvan verkregen voorwerpen.
NL7609292A (nl) Werkwijze voor het bereiden van heteroarylben- zoxepine-azijnzuren, voorlopers en derivaten daarvan.
NL182312C (nl) Werkwijze voor de bereiding van meerwaardige, aromatische cyaanzuuresters.
NL7604129A (nl) Werkwijze voor de bereiding van hydroxycarbon- zuren en derivaten ervan.
NL182313C (nl) Werkwijze voor de bereiding van meerwaardige, aromatische cyaanzuuresters.
NL179729C (nl) Werkwijze ter bereiding van farmaceutische preparaten op basis van 1h-indazool-3-carbonzuurderivaten alsmede werkwijze ter bereiding van deze 1h-indazool-3-carbonzuurderivaten.
NL173523B (nl) Werkwijze ter bereiding van farmaceutische preparaten met werking op het centrale zenuwstelsel op basis van triazoloÿ4.3-aÿÿ1.4ÿbenzodiazepinederivaten, alsmede werkwijze ter bereiding van triazoloÿ4.3-aÿÿ1.4ÿbenzodiazepinederivaten geschikt voor gebruik bij deze werkwijze.
NL7415414A (nl) Hydratropazuurderivaten en werkwijze voor de bereiding daarvan.
NL7606906A (nl) Werkwijze voor de bereiding van thymol.
NL174045B (nl) Werkwijze ter bereiding van farmaceutische preparaten met werking op het centrale zenuwstelsel op basis van 6h-thieno-Ÿ3,2-fŸ-s-triazoloŸ4,3-aŸ Ÿ1,4Ÿdiazepinederivaten, alsmede werkwijze ter bereiding van deze derivaten.
NL167697B (nl) Werkwijze ter bereiding van een farmaceutisch preparaat met werking op het centrale zenuwstelsel op basis van 5-fenylbenzodiazepinederivaten, alsmede werkwijze ter bereiding van 5-fenylbenzodiazepinederivaten, geschikt voor gebruik bij deze werkwijze.
NL7612894A (nl) Werkwijze voor de bereiding van heterocycli- sche verbindingen met een werking op het centra- le zenuwstelsel, werkwijze voor de bereiding van een geneesmiddel met een dergelijke werking en geneesmiddel.
NL7601985A (nl) Werkwijze voor de bereiding van benz(f)-2,5-oxa- zocinen.
NL7608164A (nl) Werkwijze voor het bereiden van cefem- en penamverbindingen, alsmede werkwijze ter bereiding van farmaceutische preparaten.
NL7612320A (nl) Werkwijze voor het bereiden van thiaprostaan- zuurderivaten.
NL7410493A (nl) Werkwijze voor het bereiden van o-fenylthiono- fosfor(fosfon)-zuuresteramide- respectievelijk -imidederivaten, alsmede de toepassing daarvan als insecticiden en acariciden.
NL7609662A (nl) Werkwijze voor het bereiden van op de 14-plaats gesubstitueerde vincaan-derivaten en werkwijze voor de bereiding van een geneesmiddel met vaso-actieve en spasmolytische werking.
NL7605837A (nl) Werkwijze voor de bereiding van thenoylazijn- zuurderivaten.
NL183356C (nl) Werkwijze voor het bereiden van een farmaceutisch preparaat met stimulerende werking op het centrale zenuwstelsel, alsmede werkwijze ter bereiding van voor toepassing bij eerstgenoemde werkwijze geschikte 5-gesubstitueerde 2-oxopyrrolidinederivaten met een ring-heteroatoom op de 4-positie.
NL171585C (nl) Werkwijze voor de bereiding van farmaceutische preparaten met werking op het centrale zenuwstelsel op basis van 6-fenyl-1-oxoimidazo-Ÿ1,2-aŸbenzoŸfŸ-1,4-diazepinen en werkwijze voor de bereiding van deze verbindingen.

Legal Events

Date Code Title Description
BC A request for examination has been filed
A85 Still pending on 85-01-01
AC1 Application for a supplementary protection certificate

Free format text: 940007, 940421

KC1 Grant of a supplementary protection certificate

Free format text: 940007, 950405, EXPIRES:20000404

V4 Discontinued because of reaching the maximum lifetime of a patent